Clinical trials in the Eastern Mediterranean Region: a ten-year landscape analysis
Journal of Global Health · 2026
DOI: 10.7189/jogh.16.04287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, 2026. Verfasst von Shrouk M Abdou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science, Information and Dissemination, World Health Organization Eastern Mediterranean Region, Cairo, Egypt. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In 2022, the World Health Organization (WHO) called on countries to strengthen their capacities for the conduct of impactful clinical trials and generating high-quality evidence on health interventions. The Eastern Mediterranean Region (EMR) faces challenges in this regard, with research output concentrated in a few countries and institutions.
Methods
We analysed the registration data of clinical trials from the WHO International Clinical Trials Registry Platform for all 22 countries and territories of the EMR from 2013 to 2023. Following data cleaning, deduplication, and intervention classification, we descriptively analysed the trials across time, countries, intervention types, phase, sample size, sponsorship, and participant demographics.
Results
We identified 49,529 interventional trials, representing a three-fold increase in annual registrations over the decade. Most studies conducted in 2023 originated from only a few countries: Iran (57%), Egypt (23%), and Pakistan (14%), followed by Saudi Arabia (1.5%), Iraq (1.4%), and Tunisia (1.2%). Despite the increase in absolute numbers, the proportion of clinical trials with pharmacological interventions declined from 61.5% in 2013 to 42.4% in 2023. While the findings demonstrate significant growth in regional clinical trial activity, they also highlight persistent challenges, as interventional studies with small sample sizes remain common.
Conclusions
Although our analysis reveals substantial growth in clinical trial registrations across the EMR over the past decade, persistent disparities in research capacity remain, while the role of industry remains limited. Coordinated efforts are required to increase multi-centre and multi-country studies in order to address the key health priorities and contribute more effectively to the development of solutions that address regional needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Science, Information and Dissemination, World Health Organization Eastern Mediterranean Region, Cairo, Egypt.
- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Research for Health, World Health Organization, Geneva, Switzerland.
Zitieren
APA
Abdou, S. M., Fotouhi, A., Altaf, A., Karam, G., & Rashidian, A. (2026). Clinical trials in the Eastern Mediterranean Region: a ten-year landscape analysis. Journal of Global Health. https://doi.org/10.7189/jogh.16.04287
Vancouver
Abdou SM, Fotouhi A, Altaf A, Karam G, Rashidian A. Clinical trials in the Eastern Mediterranean Region: a ten-year landscape analysis. Journal of Global Health. 2026. doi:10.7189/jogh.16.04287
BibTeX
@article{Abdou2026,
author = {Abdou, Shrouk M and Fotouhi, Akbar and Altaf, Arshad and Karam, Ghassan and Rashidian, Arash},
title = {Clinical trials in the Eastern Mediterranean Region: a ten-year landscape analysis},
journal = {Journal of Global Health},
year = {2026},
doi = {10.7189/jogh.16.04287}
}
EUVIMED